Lucid Diagnostics Announces Positive Data from ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing

Stock Information for Lucid Diagnostics Inc.

Loading

Please wait while we load your information from QuoteMedia.